Medelis, Inc. logo

Medelis, Inc.

A specialty oncology CRO and a pioneer in immunotherapy studies.

28 employees · est. 2003 · United States

VS
TESARO, Inc. logo

TESARO, Inc.

62 employees · est. 2010 · Waltham, United States

Medelis, Inc. is the older company (2003 vs 2010); TESARO, Inc. is the larger of the two.

Side-by-Side Comparison

Medelis, Inc. TESARO, Inc.
Founded
2003 older 2010
Headquarters
United States Waltham, United States
Employees
28 62 larger
Industry
Biotechnology, Pharmaceutical, Clean Energy Biopharma, Biotechnology, Health Care
Funding Stage
Not tracked yet Post Ipo Equity
Total Funding
Not tracked yet $1.10B
Funding Rounds
Not tracked yet 8
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Oncology CRO, Immunotherapy, Oncology Trials, Drug Development, Clinical Operations, Preclinical Trials, Phase 1 Trials, Phase 2 Trials, Phase 3 Trials, North America, Europe, Immuno-Oncology, Medical Writing, Biostatistics Oncology-focused, Biopharmaceuticals, Drug Development, Cancer Treatment, Neurokinin-1 Receptor Antagonist, Chemotherapy Induced Nausea And Vomiting, Phase 2 Clinical Testing, Phase 3 Clinical Testing, ALK Inhibitor Program, Drug Candidates, Commercialization, MGI PHARMA, Eisai Co., Ltd., Waltham, Massachusetts
Website
medelis.com tesarobio.com
Medelis, Inc. logo

About Medelis, Inc.

Medelis, Inc. is a specialty oncology CRO that prides itself on its pioneering work in immunotherapy studies. Founded in 2003, the company has carved a niche for itself in the preclinical and phase 1 through phase 3 oncology trials in North America and Europe. Medelis sets itself apart by offering...

TESARO, Inc. logo

About TESARO, Inc.

TESARO, Inc. is an oncology-focused business within GlaxoSmithKline (GSK) with a clear mission dedicated to improving the oncology experience. The company's commitment to unconditional care puts science for patients first. Founded in 2010 and headquartered in the United States, TESARO operates withi...

We will tell you when either one moves

BounceWatch watches Medelis, Inc. and TESARO, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Medelis, Inc. and TESARO, Inc. — by email.

Frequently Asked Questions

Medelis, Inc. — A specialty oncology CRO and a pioneer in immunotherapy studies.. TESARO, Inc.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Medelis, Inc. has raised undisclosed funding while TESARO, Inc. has raised $1.10B.
Medelis, Inc. and TESARO, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Medelis, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Medelis, Inc. on 14 Sep 2024, and TESARO, Inc. on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy